• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压相关勃起功能障碍的新见解。

New insights into hypertension-associated erectile dysfunction.

机构信息

Department of Physiology, Georgia Health Sciences University, Georgia, Augusta, USA.

出版信息

Curr Opin Nephrol Hypertens. 2012 Mar;21(2):163-70. doi: 10.1097/MNH.0b013e32835021bd.

DOI:10.1097/MNH.0b013e32835021bd
PMID:22240443
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4004343/
Abstract

PURPOSE OF REVIEW

Erectile dysfunction is recognized as a quality-of-life disorder that needs to be treated. Currently, it is estimated to affect as many as 30 million American men. Thirty percent of hypertensive patients complain of erectile dysfunction. The understanding of common mechanisms involved in the cause of erectile dysfunction associated with hypertension, and the investigation of antihypertensive drugs that impact erectile dysfunction, will provide important tools toward identifying new therapeutic targets that will improve the quality of life for patients in these conditions.

RECENT FINDINGS

Hypertension and erectile dysfunction are closely intertwined diseases, which have endothelial dysfunction as a common base. During hypertension and/or erectile dysfunction, disturbance of endothelium-derived factors can lead to an increase in vascular smooth muscle (VSM) contraction. Hypertension can lead to erectile dysfunction as a consequence of high blood pressure (BP) or due to antihypertensive treatment. However, growing evidence suggests erectile dysfunction is an early sign for hypertension. Also, some phosphodiesterase-5 inhibitors used to treat erectile dysfunction can improve BP, but the link between these conditions has not been totally understood.

SUMMARY

This review will discuss the interplay between hypertension and erectile dysfunction, exploring newest insights regarding hypertension-associated erectile dysfunction, as well as the effect of antihypertensive drugs in erectile dysfunction patients.

摘要

目的综述

勃起功能障碍被认为是一种需要治疗的生活质量障碍。目前,据估计,多达 3000 万美国男性受到影响。30%的高血压患者抱怨勃起功能障碍。了解与高血压相关的勃起功能障碍的常见发病机制,以及研究影响勃起功能障碍的降压药物,将为确定新的治疗靶点提供重要工具,这些靶点将提高这些疾病患者的生活质量。

最新发现

高血压和勃起功能障碍是密切相关的疾病,内皮功能障碍是它们共同的基础。在高血压和/或勃起功能障碍期间,内皮衍生因子的紊乱可导致血管平滑肌(VSM)收缩增加。高血压可导致勃起功能障碍,原因是血压升高(BP)或降压治疗。然而,越来越多的证据表明勃起功能障碍是高血压的早期迹象。此外,一些用于治疗勃起功能障碍的磷酸二酯酶-5 抑制剂可改善血压,但这些情况之间的联系尚未完全理解。

总结

本文将讨论高血压和勃起功能障碍之间的相互作用,探讨与高血压相关的勃起功能障碍的最新见解,以及降压药物对勃起功能障碍患者的影响。

相似文献

1
New insights into hypertension-associated erectile dysfunction.高血压相关勃起功能障碍的新见解。
Curr Opin Nephrol Hypertens. 2012 Mar;21(2):163-70. doi: 10.1097/MNH.0b013e32835021bd.
2
Management of Erectile Dysfunction: An Under-Recognition of Hypertension.勃起功能障碍的管理:对高血压的认识不足。
Curr Pharm Des. 2018;24(30):3506-3519. doi: 10.2174/1381612824666180828104350.
3
Update of the position paper on arterial hypertension and erectile dysfunction.动脉高血压与勃起功能障碍专题论文更新。
J Hypertens. 2020 Jul;38(7):1220-1234. doi: 10.1097/HJH.0000000000002382.
4
[Treatment of erectile dysfunction in patients with essential hypertension and ischemic heart disease].[原发性高血压和缺血性心脏病患者勃起功能障碍的治疗]
Ter Arkh. 2008;80(4):60-3.
5
Cardiovascular disease, metabolic syndrome and erectile dysfunction.心血管疾病、代谢综合征与勃起功能障碍。
Curr Opin Urol. 2006 Nov;16(6):435-43. doi: 10.1097/01.mou.0000250284.83108.a6.
6
Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient.高血压患者勃起功能障碍的评估与管理
Curr Cardiol Rep. 2017 Aug 24;19(9):89. doi: 10.1007/s11886-017-0889-z.
7
Endothelial dysfunction as a cause of erectile dysfunction--misdiagnosis or misnomer?内皮功能障碍作为勃起功能障碍的一个病因——误诊还是用词不当?
Urology. 2004 Aug;64(2):193-4. doi: 10.1016/j.urology.2004.04.048.
8
PDE5 inhibitors: targeting erectile dysfunction in diabetics.PDE5 抑制剂:针对糖尿病患者的勃起功能障碍。
Curr Opin Pharmacol. 2011 Dec;11(6):683-8. doi: 10.1016/j.coph.2011.08.004. Epub 2011 Sep 15.
9
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function.与内皮功能障碍及血管功能介质相关的勃起功能障碍的病理生理学
Vasc Med. 2002 Aug;7(3):213-25. doi: 10.1191/1358863x02vm429ra.
10
Erectile dysfunction in the cardiac patient.心脏病患者的勃起功能障碍
Curr Urol Rep. 2003 Dec;4(6):466-71. doi: 10.1007/s11934-003-0028-9.

引用本文的文献

1
Cost comparison of phosphodiesterase type 5 inhibitors: rural vs urban New York State counties and online pharmacies.5型磷酸二酯酶抑制剂的成本比较:纽约州农村与城市县以及在线药房
Sex Med. 2025 Jun 10;13(3):qfaf031. doi: 10.1093/sexmed/qfaf031. eCollection 2025 Jun.
2
Sexual health and function in liver disease.肝脏疾病中的性健康与功能
Hepatol Commun. 2025 Apr 3;9(4). doi: 10.1097/HC9.0000000000000691. eCollection 2025 Apr 1.
3
Perioperative infection prevention during inflatable penile prosthesis surgery: a narrative review.

本文引用的文献

1
Calcium channel blockers.钙通道阻滞剂。
J Clin Hypertens (Greenwich). 2011 Sep;13(9):687-9. doi: 10.1111/j.1751-7176.2011.00513.x. Epub 2011 Jul 27.
2
Effect of angiotensin II and its receptor antagonists on human corpus cavernous contractility and oxidative stress: modulation of nitric oxide mediated relaxation.血管紧张素 II 及其受体拮抗剂对人海绵体收缩性和氧化应激的影响:一氧化氮介导的松弛调节。
J Urol. 2011 Jun;185(6):2414-20. doi: 10.1016/j.juro.2011.02.2645. Epub 2011 Apr 21.
3
Effects of hydrogen sulfide on erectile function and its possible mechanism(s) of action.
可膨胀阴茎假体手术围手术期感染的预防:一项叙述性综述
Transl Androl Urol. 2024 Aug 31;13(8):1628-1640. doi: 10.21037/tau-23-497. Epub 2024 Aug 26.
4
Oxidative Stress and Erectile Dysfunction: Pathophysiology, Impacts, and Potential Treatments.氧化应激与勃起功能障碍:病理生理学、影响及潜在治疗方法
Curr Issues Mol Biol. 2024 Aug 14;46(8):8807-8834. doi: 10.3390/cimb46080521.
5
Symptom burden in chronic liver disease.慢性肝病中的症状负担
Gastroenterol Rep (Oxf). 2024 Aug 9;12:goae078. doi: 10.1093/gastro/goae078. eCollection 2024.
6
Cardiometabolic Disorder and Erectile Dysfunction.心脏代谢紊乱与勃起功能障碍。
Cell Biochem Biophys. 2024 Sep;82(3):1751-1762. doi: 10.1007/s12013-024-01361-2. Epub 2024 Jun 22.
7
Composition Characterization of Kanehira Hydrosol and Its Enhanced Effects on Erectile Function.钟平水溶胶的成分表征及其对勃起功能的增强作用。
Plants (Basel). 2024 May 31;13(11):1518. doi: 10.3390/plants13111518.
8
A Systematic Review and Meta-Analysis of the Predictive Power of China-PAR Against Cardiovascular Disease.中国高血压知晓率、治疗率和控制率与心血管病关系的系统评价和 Meta 分析
Clin Med Res. 2024 Mar;22(1):28-36. doi: 10.3121/cmr.2024.1846.
9
The design, implementation, and impact of an automated patient-reported outcome data collection and adverse event surveillance tool: a randomized trial.自动化患者报告结局数据采集和不良事件监测工具的设计、实施和影响:一项随机试验。
BMC Health Serv Res. 2023 Nov 20;23(1):1277. doi: 10.1186/s12913-023-10231-1.
10
Is There a Correlation between Endoscopic Sinus Surgery and Improvement in Erectile Dysfunction?内窥镜鼻窦手术与勃起功能障碍改善之间存在关联吗?
J Clin Med. 2023 Oct 19;12(20):6626. doi: 10.3390/jcm12206626.
硫化氢对勃起功能的影响及其可能的作用机制。
J Sex Med. 2011 Jul;8(7):1853-64. doi: 10.1111/j.1743-6109.2011.02279.x. Epub 2011 Apr 14.
4
Hydrogen sulfide and erectile function: a novel therapeutic target.硫化氢与勃起功能:一个新的治疗靶点。
Nat Rev Urol. 2011 May;8(5):286-9. doi: 10.1038/nrurol.2011.45. Epub 2011 Apr 5.
5
Vital signs: prevalence, treatment, and control of hypertension--United States, 1999-2002 and 2005-2008.生命体征:1999-2002 年和 2005-2008 年美国高血压的流行率、治疗和控制情况。
MMWR Morb Mortal Wkly Rep. 2011 Feb 4;60(4):103-8.
6
The role of Beta-blockers as first-line therapy in hypertension.β受体阻滞剂在高血压治疗中的一线地位。
Curr Atheroscler Rep. 2011 Apr;13(2):147-53. doi: 10.1007/s11883-010-0157-9.
7
Endothelins & erectile dysfunction.内皮素与勃起功能障碍。
Pharmacol Res. 2011 Jun;63(6):496-501. doi: 10.1016/j.phrs.2010.12.006. Epub 2010 Dec 23.
8
Erectile dysfunction: a disease marker for cardiovascular disease.勃起功能障碍:心血管疾病的一个疾病标志物。
Cardiol Rev. 2011 Jan-Feb;19(1):5-11. doi: 10.1097/CRD.0b013e3181fb7eb8.
9
RhoA/Rho-kinase and vascular diseases: what is the link?RhoA/Rho-kinase 与血管疾病:有何关联?
Cell Mol Life Sci. 2010 Nov;67(22):3823-36. doi: 10.1007/s00018-010-0460-1. Epub 2010 Jul 29.
10
Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets.内皮衍生的血管活性因子与高血压:在发病机制中的可能作用及作为治疗靶点。
Curr Hypertens Rep. 2010 Aug;12(4):267-75. doi: 10.1007/s11906-010-0118-2.